This dysregulation may contribute directly to the tumor hypersecretion phenotypes that are caused by more than twenty of the different neuropeptides and hormones abnormally released from DCVs such as gastrin-releasing peptide, chromogranin A, atrial natriuretic peptide (ANP), and growth hormone-releasing hormone [66]–[69]. The gene discussed is GRP; the disease is neoplasm.